Pharmaceutical Marketplace Reform

Author : Sara Schlenkrich
Publisher : diplom.de
Page : 66 pages
File Size : 47,9 Mb
Release : 2015-02-01
Category : Medical
ISBN : 9783954898596

Get Book

The Act on the Reform of the Market for Medicinal Products (AMNOG): A question of power?! by Sara Schlenkrich Pdf

In the past, high costs have been incurred in particular by the market launch of new medicinal products. To date, it was not necessary to demonstrate an additional therapeutic benefit. This changed with the Act on the Reform of the Market for Medicinal Products (AMNOG), which entered into force on the 1st of January 2011. It brought about a fundamental change in the balance of power on the pharmaceutical market. This study therefore sets out to answer the following question: What impact does the early benefit assessment in the context of the AMNOG have on the stakeholders of the healthcare system? To answer this question, this survey first presents the theoretical foundations of the law, of the early benefit assessment and the bodies involved. It then takes stock of the decisions taken to date before describing the impact on the selected stakeholders.

Author : United States. Congress. Senate. Special Committee on Aging
Publisher : Unknown
Page : 360 pages
File Size : 43,6 Mb
Release : 1994
Category : Business & Economics
ISBN : STANFORD:36105021024661

Get Book

Pharmaceutical Marketplace Reform by United States. Congress. Senate. Special Committee on Aging Pdf

Author : Reji K. Joseph
Publisher : Routledge
Page : 250 pages
File Size : 54,5 Mb
Release : 2015-07-24
Category : Business & Economics
ISBN : 9781317408833

Get Book

Pharmaceutical Industry and Public Policy in Post-reform India by Reji K. Joseph Pdf

This book examines the impact of economic reforms in India on the pharmaceutical industry and access to medicines. It traces the changing production and trade pattern of the industry, research and development (R&D) preferences and strategies of Indian pharmaceutical firms, patent system alongside pricing policy measures and their shortcomings. It also analyses the public health financing system in India driven largely by out-of-pocket expenditure — about 60 per cent — and characterised by very high share of medicines in total health expenditure. A masterful insight into a topical area, the work will be indispensable to those working on pharmaceutical industry and public policy. It will be of interest to researchers, scholars, students, and policy-makers of economics, industrial policy, public policy, intellectual property rights and health financing.

Author : United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness
Publisher : Unknown
Page : 100 pages
File Size : 52,8 Mb
Release : 2003
Category : Law
ISBN : STANFORD:36105050337109

Get Book

The economic aspects of the pharmaceutical industry in the United States by United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness Pdf

Author : Anna Cook
Publisher : Unknown
Page : 88 pages
File Size : 44,7 Mb
Release : 1994
Category : Drugs
ISBN : UOM:39015032628367

Get Book

How Health Care Reform Affects Pharmaceutical Research and Development by Anna Cook Pdf

Author : Henry I. Miller, MD
Publisher : Hoover Institution Press
Page : 128 pages
File Size : 43,5 Mb
Release : 2000-08-01
Category : Political Science
ISBN : 9780817999025

Get Book

To America's Health by Henry I. Miller, MD Pdf

A government monopoly over drug regulation is not sacrosanct. In fact, federal oversight--which vitally affects the availability of drugs to patients in need--is in shambles. The regulatory monopoly of the federal Food and Drug Administration has become, literally, overkill and actually threatens public health. Regulatory reform that introduces competition and incentives to get safe, effective drugs to patients can, however, transform the drug development process and reverse the current upward spiral of time and costs. The public will benefit directly by earlier access to greater numbers of less costly drugs and indirectly by greater robustness and productivity in the pharmaceutical industry.

Author : Ray Moynihan,Kerstin Blum,Reinhard Busse,Sophia Schlette
Publisher : Verlag Bertelsmann Stiftung
Page : 163 pages
File Size : 54,5 Mb
Release : 2010-07-30
Category : Health & Fitness
ISBN : 9783867932745

Get Book

Health Policy Developments 12 by Ray Moynihan,Kerstin Blum,Reinhard Busse,Sophia Schlette Pdf

While care coordination and quality of care remain paramount policy topics everywhere, countries again turn to payment and efficiency challenges. Issue 12 of Health Policy Developments examines how health systems are trying to maximize value for money - exploring new avenues and mixing incentives. Preceding the value question there is a much simpler question: Where does the money come from? Clearly, someone needs to shoulder the burden of higher healthcare costs, but who should pay for what? Should it be private health insurers or the pharmaceutical industry as is happening in France and Australia, the whole population as it is in Finland or Canada, or should people above a certain body mass index be taxed, as in Alabama? Further topics in this issue are governance in Bismarckian systems, responsiveness of health systems to vulnerable groups, access and equity, and patient safety and quality. The International Network Health Policy and Reform aims to narrow the gap between health services research and health policy. Network partners are research institutions and health policy experts from 20 industrialized countries.

Author : Marc J. Roberts
Publisher : World Bank Publications
Page : 357 pages
File Size : 52,9 Mb
Release : 2011-09-21
Category : Medical
ISBN : 9780821387603

Get Book

Pharmaceutical Reform by Marc J. Roberts Pdf

This book applies an established analytical framework for health sector reform (Getting Health Reform Right, Oxford, 2004) to the performance problems of the pharmaceutical sector. The book is divided into three sections. The first section presents the basic ideas for analysis. It begins by insisting that reform start with a clear understanding of the performance deficiencies of the current system. Like all priority setting in the public sector, this 'definition of the problem' involves both ethical choices and political processes. Early chapters explain the foundations of these ideas and apply them to the pharmaceutical sector. The relationship of ultimate outcomes (like health status or risk protection) to classic health systems concepts like efficiency, access and quality is also explored. The last chapter in the first part is devoted to 'diagnosis'—explaining how to move from the definition of a problem to an understanding of how the functioning of the system produces the undesirable outcomes in question. The second part of the book devotes one chapter to each of five 'control knobs': finance, payment, organization, regulation and persuasion. These are sets of potential interventions that governments can use to improve pharmaceutical sector performance. Each chapter presents basic concepts and discusses examples of reform options. Throughout we provide 'conditional guidance'—avoiding the approach of a 'one size fits all' model of 'best practices' in these five arenas for reform. Instead we stress the need for local knowledge of political systems, administrative capacities, community values and market conditions in order to design pharmaceutical sector policies appropriate to a country’s particular circumstances. The last part of the book is a set of teaching cases. Each is preceded by questions and is followed by a brief note on the lessons to be learned. The goal is to help readers develop the skills they need to deal effectively with pharmaceutical sector reform problems in their own countries.

Author : Dominique A. Tobbell
Publisher : Univ of California Press
Page : 310 pages
File Size : 47,9 Mb
Release : 2012
Category : Medical
ISBN : 9780520271142

Get Book

Pills, Power, and Policy by Dominique A. Tobbell Pdf

"Tobbell analyzes the political and economic history of the alignment of the pharmaceutical industry, academic institutions and their faculty and organized medicine. This book is essential reading for policymakers and their staff as well as persons who study the history of health policy and those who contribute to it through medical research, advocacy and journalism. " -Daniel Fox, author of The Convergence of Science and Governance: Research, Health Policy, and American States "Dominique Tobbell’s vivid, balanced and probing account of pharmaceutical politics is a significant, needed analysis of the relationships between the pharmaceutical industry, university researchers, the medical profession and government in the Cold War period. More than this, Pills, Power, and Policy shows why it continues to be difficult to agree in the United States on the relative roles of corporate enterprise, government regulation, technological innovation, freedom to prescribe, and consumer marketing and protection, all played out against the rising costs of health care. Timely and thought-provoking."--Rosemary A. Stevens. DeWitt Wallace Distinguished Scholar, Department of Psychiatry, Weill Cornell Medical College "A superb and compelling account of the creation of one of America’s most reviled entities: Big Pharma. With clarity and subtlety, Pills, Power, and Policy weaves together the political, economic, and the medical to reveal the entangled history behind our modern pharmaceutical predicament."--Andrea Tone, Ph.D., Professor of History & Canada Research Chair in the Social History of Medicine, McGill University “Pills, Power and Policy provides an outstanding description and analysis of the evolution of drug policy. It is an extremely important contribution to our understanding of the political, scientific, and economic nature of pharmaceutical regulation." -Daniel S. Greenberg, Washington journalist and author of Science, Money and Politics: Political Triumph and Ethical Erosion

Author : Anonim
Publisher : Forgotten Books
Page : 328 pages
File Size : 43,6 Mb
Release : 2018-02-12
Category : Reference
ISBN : 0656383046

Get Book

Pharmaceutical Marketplace Reform; Is Competition the Right Prescription? by Anonim Pdf

Excerpt from Pharmaceutical Marketplace Reform; Is Competition the Right Prescription?: Hearing Before the Special Committee on Aging, United States Senate, One Hundred Third Congress, First Session, Washington, DC, November 16, 1993 This hearing this morning is going to focus on an issue that is very important to all of us on this Committee and to all of us in this room, to millions of older Americans, and all the various health care plans that purchase prescription medications. We are going to try to answer a very simple question this morning. It re quires a lot of complex issues to wade through before we finally are going to find the ultimate solution. That ultimate solution and swer may not come until sometime next year, perhaps even the year after. But we hope we will be answering that question. The question is this: Will market forces and market competition be adequate to hold down drug prices? If the past says anything about the future, we may want to proceed with a bit of caution. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.

Author : Joel Lexchin
Publisher : University of Toronto Press
Page : 384 pages
File Size : 40,6 Mb
Release : 2016-10-27
Category : Health & Fitness
ISBN : 9781442619616

Get Book

Private Profits versus Public Policy by Joel Lexchin Pdf

The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren’t the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies’ quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public’s favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years.

Author : United States Congress Senate Special
Publisher : Palala Press
Page : 324 pages
File Size : 45,8 Mb
Release : 2018-02-19
Category : History
ISBN : 1378135156

Get Book

Pharmaceutical Marketplace Reform: Is Competition the Right Prescription?: Hearing Before the Special Committee on Aging, United States Senate, One Hu by United States Congress Senate Special Pdf

This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work. This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.

Author : United States. Congress. Senate. Special Committee on Aging
Publisher : Unknown
Page : 324 pages
File Size : 52,6 Mb
Release : 1994
Category : Business & Economics
ISBN : PSU:000022347176

Get Book

Pharmaceutical Marketplace Reform by United States. Congress. Senate. Special Committee on Aging Pdf

Author : Committee to Study Medication Development and Research at the National Institute on Drug Abuse,Institute of Medicine
Publisher : National Academies Press
Page : 271 pages
File Size : 40,7 Mb
Release : 1995-02-03
Category : Medical
ISBN : 9780309587914

Get Book

The Development of Medications for the Treatment of Opiate and Cocaine Addictions by Committee to Study Medication Development and Research at the National Institute on Drug Abuse,Institute of Medicine Pdf

Pharmacotherapy, as a means of treating drug addiction in combination with other treatment modalities, has received too little attention from the research community, the pharmaceutical industry, public health officials, and the federal government. Medications to combat drug addiction could have an enormous impact on the medical consequences and socioeconomic problems associated with drug abuse, both for drug-dependent individuals and for American society as a whole. This book examines the current environment for and obstacles to the development of anti-addiction medications, specifically those for treating opiate and cocaine addictions, and proposes incentives for the pharmaceutical industry that would help overcome those obstacles and accelerate the development of anti-addiction medications.

Author : Ramesh Govindaraj,Gnanaraj Chellaraj
Publisher : World Bank Publications
Page : 78 pages
File Size : 46,8 Mb
Release : 2002-01-01
Category : Medical
ISBN : 0821352121

Get Book

The Indian Pharmaceutical Sector by Ramesh Govindaraj,Gnanaraj Chellaraj Pdf

The Indian pharmaceutical market ranks as the world's third largest in terms of volume, and has been growing at an annual rate of over 10 per cent over the last decade. Pharmaceutical policy in India is perceived primarily from an industrial perspective rather than a health sector priority, and is governed by a complex variety of laws and policies. This report reviews recent policy initiatives and their economic and health sector implications. It considers the profound gap that exists between the benefits which pharmaceuticals have to offer, and the reality that for millions of poor people in India medicines are often unaffordable, unsafe or improperly used. The report outlines some strategic options that could strengthen India's ability to ensure the availability, affordability, quality and rational use of essential medicines on a sustainable basis, using a mix of public and private sector resources.